320 related articles for article (PubMed ID: 16491981)
41. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
Høyberg OJ; Maragakis B; Mullin J; Norum D; Stordall E; Ekdahl P; Ose E; Moksnes KM; Sennef C
Acta Psychiatr Scand; 1996 Mar; 93(3):184-90. PubMed ID: 8739664
[TBL] [Abstract][Full Text] [Related]
42. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
[TBL] [Abstract][Full Text] [Related]
43. Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
Fusar-Poli P; Matteo L; Luca de M; Politi P; Cortesi M; Carboni V
J Psychosom Res; 2007 Jan; 62(1):101. PubMed ID: 17188127
[No Abstract] [Full Text] [Related]
44. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
Bech P
Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
[TBL] [Abstract][Full Text] [Related]
45. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
Szegedi A; Jansen WT; van Willigenburg AP; van der Meulen E; Stassen HH; Thase ME
J Clin Psychiatry; 2009 Mar; 70(3):344-53. PubMed ID: 19254516
[TBL] [Abstract][Full Text] [Related]
46. Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.
Chang HS; Won ES; Lee HY; Ham BJ; Kim YG; Lee MS
J Psychopharmacol; 2015 May; 29(5):615-22. PubMed ID: 25294870
[TBL] [Abstract][Full Text] [Related]
47. The effect of placebo administration on the first-night effect in healthy young volunteers.
Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
[TBL] [Abstract][Full Text] [Related]
48. The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
Brunnauer A; Laux G; David I; Fric M; Hermisson I; Möller HJ
J Clin Psychiatry; 2008 Dec; 69(12):1880-6. PubMed ID: 19203476
[TBL] [Abstract][Full Text] [Related]
49. Mirtazapine in major depression with comorbid generalized anxiety disorder.
Goodnick PJ; Puig A; DeVane CL; Freund BV
J Clin Psychiatry; 1999 Jul; 60(7):446-8. PubMed ID: 10453798
[TBL] [Abstract][Full Text] [Related]
50. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss.
Jiang SM; Jia L; Liu J; Shi MM; Xu MZ
World J Gastroenterol; 2016 Jun; 22(22):5260-6. PubMed ID: 27298569
[TBL] [Abstract][Full Text] [Related]
51. Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder.
Emslie GJ; Armitage R; Weinberg WA; Rush AJ; Mayes TL; Hoffmann RF
Int J Neuropsychopharmacol; 2001 Jun; 4(2):159-68. PubMed ID: 11466166
[TBL] [Abstract][Full Text] [Related]
52. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
[TBL] [Abstract][Full Text] [Related]
53. Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression.
van Moffaert M; de Wilde J; Vereecken A; Dierick M; Evrard JL; Wilmotte J; Mendlewicz J
Int Clin Psychopharmacol; 1995 Mar; 10(1):3-9. PubMed ID: 7622801
[TBL] [Abstract][Full Text] [Related]
54. Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report.
Safer DL; Darcy AM; Lock J
Int J Eat Disord; 2011 Mar; 44(2):178-81. PubMed ID: 20127940
[TBL] [Abstract][Full Text] [Related]
55. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
Schmid DA; Wichniak A; Uhr M; Ising M; Brunner H; Held K; Weikel JC; Sonntag A; Steiger A
Neuropsychopharmacology; 2006 Apr; 31(4):832-44. PubMed ID: 16237393
[TBL] [Abstract][Full Text] [Related]
56. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism.
Onofrj M; Luciano AL; Thomas A; Iacono D; D'Andreamatteo G
Neurology; 2003 Jan; 60(1):113-5. PubMed ID: 12525729
[TBL] [Abstract][Full Text] [Related]
57. Effect of sertraline on breathing in depressed patients without moderate-to-severe sleep-related breathing disorders.
Zhang B; Hao Y; Jia F; Li X; Tang Y; Zheng H; Liu W
Sleep Breath; 2015 Dec; 19(4):1377-86. PubMed ID: 25758299
[TBL] [Abstract][Full Text] [Related]
58. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
59. Sertraline- and mirtazapine-induced severe neutropenia.
Ozcanli T; Unsalver B; Ozdemir S; Ozmen M
Am J Psychiatry; 2005 Jul; 162(7):1386. PubMed ID: 15994730
[No Abstract] [Full Text] [Related]
60. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
